Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis, Viral, Human”

4,091 trials

Showing 20 of 4,091 results

Post-approval studies (Phase 4)Ended earlyNCT01606800
What this trial is testing

Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 45
Early research (Phase 1)Study completedNCT01070407
What this trial is testing

A New Candidate Vaccine Against Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
ReiThera Srl 41
Testing effectiveness (Phase 2)Study completedNCT04535544
What this trial is testing

JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

Who this might be right for
Hepatitis D, Chronic
Janssen Research & Development, LLC 52
Early research (Phase 1)Study completedNCT01144936
What this trial is testing

Study of VX-985 in Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 21
Large-scale testing (Phase 3)Study completedNCT01307436
What this trial is testing

Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines

Who this might be right for
Hepatitis A
Crucell Holland BV 327
Post-approval studies (Phase 4)Study completedNCT00629967
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

Who this might be right for
Chronic Hepatitis CGenotype
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Post-approval studies (Phase 4)UnknownNCT00939068
What this trial is testing

Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission

Who this might be right for
Chronic Hepatitis B, Gestation
Southeast University, China 180
Not applicableUnknownNCT03268317
What this trial is testing

Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs

Who this might be right for
Hepatitis C
Assiut University 100
Not applicableStudy completedNCT00241943
What this trial is testing

A Video-Based HCV Curriculum for Active Injection Drug Users

Who this might be right for
Hepatitis COpiate Dependence
Organization to Achieve Solutions in Substance Abuse (OASIS) 103
Large-scale testing (Phase 3)Study completedNCT02600325
What this trial is testing

Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV

Who this might be right for
Acute Hepatitis CHuman Immunodeficiency VirusHepatitis C
Erasmus Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT02174276
What this trial is testing

Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 195
Not applicableStudy completedNCT05406089
What this trial is testing

Effects of Antiviral Therapy on Patients With HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaHepatitis B VirusSurvival
First Affiliated Hospital Xi'an Jiaotong University 494
Large-scale testing (Phase 3)Study completedNCT00036608
What this trial is testing

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb
Large-scale testing (Phase 3)WithdrawnNCT01517308
What this trial is testing

24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C

Who this might be right for
Chronic Hepatitis C
Federico II University
Large-scale testing (Phase 3)WithdrawnNCT00381017
What this trial is testing

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Who this might be right for
Hepatitis CLiver CirrhosisHIV Infections
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01854697
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 311
Testing effectiveness (Phase 2)Study completedNCT01180790
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants

Who this might be right for
Hepatitis C
Alexion Pharmaceuticals, Inc. 122
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Testing effectiveness (Phase 2)Study completedNCT01816490
What this trial is testing

THISTLE - The HIV-HCV Silibinin Trial

Who this might be right for
HIVHepatitis C
University of Zurich 20
Not applicableStudy completedNCT01525810
What this trial is testing

Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 218
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation